Remepy Welcomes Pharma R&D Leader, Eran Harary, MD, as Chief Medical Officer, to Advance Hybrid Drug™ Pipeline

<p>Teva Pharmaceuticals former SVP and global innovative medicine R&D leader joins Remepy's executive management team as the Company prepares to commence Phase III of its Hybrid DrugTM for Parkinson's disease and expand its Hybrid Drug pipeline NEW YORK, September 16, 2026 /PRNewswire/ --...</p>